The company is also developing relacorilant, which is in phase III clinical trial for the treatment of hypercortisolism; relacorilant combined with nab-paclitaxel which is in phase III clinical trial ...

B7-H3, also known as CD276, is an immunoregulatory protein that is overexpressed in tumour tissue, notably in lung, breast, ovarian, gastric, and brain cancer as well as squamous cell carcinoma of ...

non-small cell lung cancer, oesophageal, ovarian, pancreatic, and prostate). Here, the synthetic mRNA encoding tumour-associated or tumour-specific antigens can be delivered through autologous ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Get Instant Summarized Text (Gist) A Phase 3 trial demonstrated that a cancer stem cell test, ChemoID, can effectively select treatments for patients with platinum-resistant ovarian cancer, leading to ...

Northwestern Medicine scientists have uncovered new details about the genetic structure of ovarian cancer stem cells, ...

To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors ... heat to damage or kill cancer cells.

This is because it directly targets cancer cells, reducing the negative effects associated with more conventional treatments. Tumours, such as some breast and ovarian cancers, can express the ...